These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11783394)

  • 21. Risk-of-malignancy index in preoperative evaluation of clinically restricted ovarian cancer.
    Torres JC; Derchain SF; Faundes A; Gontijo RC; Martinez EZ; Andrade LA
    Sao Paulo Med J; 2002 May; 120(3):72-6. PubMed ID: 12163896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ovarian tumor markers of presumed benign ovarian tumors].
    Lahlou N; Brun JL
    J Gynecol Obstet Biol Reprod (Paris); 2013 Dec; 42(8):752-9. PubMed ID: 24210243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The risk of malignancy index (RMI) in women with adnexal masses in Wales.
    Abdulrahman GO; McKnight L; Lutchman Singh K
    Taiwan J Obstet Gynecol; 2014 Sep; 53(3):376-81. PubMed ID: 25286794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer - An international multicenter study in women with an ovarian mass.
    Karlsen MA; Høgdall EV; Christensen IJ; Borgfeldt C; Kalapotharakos G; Zdrazilova-Dubska L; Chovanec J; Lok CA; Stiekema A; Mutz-Dehbalaie I; Rosenthal AN; Moore EK; Schodin BA; Sumpaico WW; Sundfeldt K; Kristjansdottir B; Zapardiel I; Høgdall CK
    Gynecol Oncol; 2015 Sep; 138(3):640-6. PubMed ID: 26086566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic extended usefulness of RMI: comparison of four risk of malignancy index in preoperative differentiation of borderline ovarian tumors and benign ovarian tumors.
    Zhang S; Yu S; Hou W; Li X; Ning C; Wu Y; Zhang F; Jiao YF; Lee LTO; Sun L
    J Ovarian Res; 2019 Sep; 12(1):87. PubMed ID: 31526390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should cut-off values of the risk of malignancy index be changed for evaluation of adnexal masses in Asian and Pacific populations?
    Yavuzcan A; Caglar M; Ozgu E; Ustun Y; Dilbaz S; Ozdemir I; Yildiz E; Gungor T; Kumru S
    Asian Pac J Cancer Prev; 2013; 14(9):5455-9. PubMed ID: 24175841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparative study of the risk of malignancy index and the ovarian crescent sign for the diagnosis of invasive ovarian cancer.
    Yazbek J; Aslam N; Tailor A; Hillaby K; Raju KS; Jurkovic D
    Ultrasound Obstet Gynecol; 2006 Sep; 28(3):320-4. PubMed ID: 16881074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The accuracy of risk malignancy index in prediction of malignancy in women with adnexal mass in Basrah, Iraq.
    Al-Asadi JN; Al-Maliki SK; Al-Dahhhan F; Al-Naama L; Suood F
    Niger J Clin Pract; 2018 Oct; 21(10):1254-1259. PubMed ID: 30297555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of risk of malignancy indices; RMI 1-4 in borderline ovarian tumor.
    Yenen MC; Alanbay I; Aktürk E; Ercan CM; Coksuer H; Karaşahin E; Ozan H; Dede M
    Eur J Gynaecol Oncol; 2012; 33(2):168-73. PubMed ID: 22611957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Preoperative identification of malignancy among women with a pelvic mass. Evaluation of a risk index based on ultrasound findings. CA 125 in serum and menopausal status].
    Hagen B; Tingulstad S; Onsrud M; Moen M; Kiserud T; Eik-Nes S; Halvorsen T; Nustad K
    Tidsskr Nor Laegeforen; 1995 Mar; 115(7):820-2. PubMed ID: 7701488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of risk of malignancy indices in evaluating ovarian masses in a Southeast Asian population.
    Ong C; Biswas A; Choolani M; Low JJ
    Singapore Med J; 2013 Mar; 54(3):136-9. PubMed ID: 23546025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved Detection Rate of Ovarian Cancer Using a 2-Step Triage Model of the Risk of Malignancy Index and Expert Sonography in an Outpatient Screening Setting.
    Manegold-Brauer G; Buechel J; Knipprath-Mészaros A; Schoetzau A; Hacker NF; Tercanli S; Lapaire O; Heinzelmann-Schwarz V
    Int J Gynecol Cancer; 2016 Jul; 26(6):1062-9. PubMed ID: 27177281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative detection of ovarian cancer by color Doppler ultrasonography and CA 125.
    Hossain F; Karim MN; Rahman SM; Khan N; Siddiqui M; Hussain R
    Bangladesh Med Res Counc Bull; 2010 Aug; 36(2):68-73. PubMed ID: 21473205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of malignancy index in the preoperative evaluation of patients with adnexal masses.
    Andersen ES; Knudsen A; Rix P; Johansen B
    Gynecol Oncol; 2003 Jul; 90(1):109-12. PubMed ID: 12821350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the risk malignancy index diagnostic value in patients with adnexal masses.
    Terzić M; Dotlić J; Ladjević IL; Atanacković J; Ladjević N
    Vojnosanit Pregl; 2011 Jul; 68(7):589-93. PubMed ID: 21899180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
    Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
    Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The risk of malignancy index for ovarian tumours in Northeast Scotland--a population based study.
    Harry VN; Narayansingh GV; Parkin DE
    Scott Med J; 2009 May; 54(2):21-3. PubMed ID: 19530497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential diagnosis of adnexal masses: sequential use of the risk of malignancy index and HistoScanning, a novel computer-aided diagnostic tool.
    Vaes E; Manchanda R; Autier P; Nir R; Nir D; Bleiberg H; Robert A; Menon U
    Ultrasound Obstet Gynecol; 2012 Jan; 39(1):91-8. PubMed ID: 21695741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer.
    Jacobs I; Oram D; Fairbanks J; Turner J; Frost C; Grudzinskas JG
    Br J Obstet Gynaecol; 1990 Oct; 97(10):922-9. PubMed ID: 2223684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The diagnostic value of PET/CT for primary ovarian cancer--a prospective study.
    Risum S; Høgdall C; Loft A; Berthelsen AK; Høgdall E; Nedergaard L; Lundvall L; Engelholm SA
    Gynecol Oncol; 2007 Apr; 105(1):145-9. PubMed ID: 17229460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.